Clik here to view.
Bristol-Myers Squibb and Infinity Pharmaceuticals Announce Clinical...
Wednesday, November 9th 2016 at 11:59am UTC Evaluation of IPI-549 as a monotherapy continuing, with combination portion of Phase 1 study expected to begin this fall Study to evaluate potential of...
View ArticleClik here to view.
Acorda Therapeutics to Present at the Stifel 2016 Healthcare Conference
Wednesday, November 9th 2016 at 12:00pm UTC ARDSLEY, N.Y.–(BUSINESS WIRE)– Acorda Therapeutics, Inc. (Nasdaq:ACOR) announced that Ron Cohen, M.D., President and CEO of Acorda Therapeutics, will...
View ArticleClik here to view.
Surmodics to Present at Canaccord Genuity Medical Technology and Diagnostics...
Wednesday, November 9th 2016 at 1:05pm UTC Webcast is Live on Thursday, November 17, at 8:20 a.m. (ET) EDEN PRAIRIE, Minn.–(BUSINESS WIRE)– Surmodics, Inc. (Nasdaq: SRDX), a leading provider of...
View ArticleClik here to view.
Synergy Pharmaceuticals Reports Third Quarter 2016 Financial Results and...
Wednesday, November 9th 2016 at 9:47pm UTC NEW YORK–(BUSINESS WIRE)– Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company focused on the development and commercialization of novel...
View ArticleClik here to view.
Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences
Wednesday, November 9th 2016 at 9:05pm UTC BEDFORD, Mass.–(BUSINESS WIRE)– Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of...
View ArticleClik here to view.
Bristol-Myers Squibb Signs Exclusive Worldwide License Agreement with Nitto...
Thursday, November 10th 2016 at 11:59am UTC Exclusive license to develop, manufacture and commercialize lead Phase 1b asset ND-L02-s0201 in development for advanced liver fibrosis Advances...
View ArticleClik here to view.
GlycoMimetics to Present at Upcoming Healthcare Investor Conferences
Thursday, November 10th 2016 at 2:00pm UTC ROCKVILLE, Md.–(BUSINESS WIRE)– GlycoMimetics, Inc. (NASDAQ: GLYC) today announced that Chief Executive Officer Rachel King will provide a company overview...
View ArticleClik here to view.
IBRANCE® (palbociclib) Receives Approval in European Union for the Treatment...
Thursday, November 10th 2016 at 7:00am UTC IBRANCE is the first and only CDK 4/6 inhibitor, a new class of anti-cancer treatments, to be approved in Europe NEW YORK–(BUSINESS WIRE)– Pfizer Inc....
View ArticleClik here to view.
Synergy Pharmaceuticals to Present at Jefferies 2016 London Healthcare...
Thursday, November 10th 2016 at 2:30pm UTC NEW YORK–(BUSINESS WIRE)– Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced the company will present a corporate update at the Jefferies London...
View ArticleClik here to view.
Bristol-Myers Squibb Enters into New Collaboration with Johns Hopkins Focused...
Thursday, November 10th 2016 at 4:19pm UTC NEW YORK–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) announced today that the company has entered into a five-year research collaboration with...
View ArticleClik here to view.
Ironwood Pharmaceuticals to Present at Stifel 2016 Healthcare Conference
Thursday, November 10th 2016 at 9:01pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the Stifel 2016 Healthcare Conference on...
View ArticleClik here to view.
EyeQue Awarded CES 2017 Best of Innovation
Thursday, November 10th 2016 at 10:00pm UTC EyeQue Personal Vision Tracker deemed most impressive product in the Fitness, Sports, and Biotech category NEW YORK & NEWARK, Calif.–(BUSINESS WIRE)–...
View ArticleClik here to view.
vTv Therapeutics to Participate in Upcoming Mizuho, Stifel and Piper Jaffray...
Thursday, November 10th 2016 at 9:30pm UTC HIGH POINT, N.C.–(BUSINESS WIRE)– vTv Therapeutics Inc. (Nasdaq:VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of...
View ArticleClik here to view.
Bristol-Myers Squibb’s Opdivo® (nivolumab) is the First Immuno-Oncology...
Thursday, November 10th 2016 at 10:00pm UTC Opdivo is the first and only Immuno-Oncology treatment proven in a Phase 3 trial to significantly extend overall survival for patients with recurrent or...
View ArticleClik here to view.
BioTime Co-CEO Dr. Michael D. West to Chair Cell Therapy Track at World...
Thursday, November 10th 2016 at 9:18pm UTC -Will Also Present at Young Jewish Professionals Life Sciences & Pharmaceuticals CEO Symposium- ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. (NYSE...
View ArticleClik here to view.
Landmark Study Demonstrates Pfizer’s Celebrex (Celecoxib)Has Similar...
Sunday, November 13th 2016 at 9:57pm UTC Patients Taking Pfizer’s Celebrex (celecoxib) Experienced Fewer Gastrointestinal Events As Compared to Prescription Doses of Ibuprofen and Naproxen — Study...
View ArticleClik here to view.
Pfizer Announces Major Expansion of Humanitarian Assistance Program
Friday, November 11th 2016 at 11:00am UTC Prevenar 13® Vaccine Will Be Available at Lowest Price for Humanitarian Emergencies Pfizer to Donate Sales Proceeds to Organizations Supporting the Refugee...
View ArticleClik here to view.
GTx Announces Webcast of Corporate Presentation at the Stifel 2016 Healthcare...
Friday, November 11th 2016 at 12:00pm UTC MEMPHIS, Tenn.–(BUSINESS WIRE)– GTx, Inc. (Nasdaq: GTXI) announced today that management will present a company overview on November 16, 2016, at the Stifel...
View ArticleClik here to view.
French Biopharma Invests in Medidata Technology to Drive Cutting-Edge Cancer...
Monday, November 14th 2016 at 1:30pm UTC NEW YORK–(BUSINESS WIRE)– Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced...
View ArticleClik here to view.
Pfizer Announces Tender Offer for Any and All of its 6.200% Senior Notes Due...
Monday, November 14th 2016 at 1:47pm UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE:PFE) today announced the commencement of a tender offer (the “Tender Offer”) to purchase for cash any and all of...
View Article